MARKET

CDXS

CDXS

Codexis Inc
NASDAQ
1.740
+0.110
+6.75%
After Hours: 1.720 -0.02 -1.15% 18:22 04/01 EDT
OPEN
1.660
PREV CLOSE
1.630
HIGH
1.825
LOW
1.660
VOLUME
1.49M
TURNOVER
--
52 WEEK HIGH
3.870
52 WEEK LOW
0.9583
MARKET CAP
158.11M
P/E (TTM)
-3.4483
1D
5D
1M
3M
1Y
5Y
1D
Codexis (CDXS) Gets a Buy from Jefferies
TipRanks · 14h ago
Weekly Report: what happened at CDXS last week (0323-0327)?
Weekly Report · 2d ago
Weekly Report: what happened at CDXS last week (0316-0320)?
Weekly Report · 03/23 10:32
Weekly Report: what happened at CDXS last week (0309-0313)?
Weekly Report · 03/16 10:31
Codexis (CDXS) Is Up 30.9% After Merck-Fueled Q4 Profit Beat And 2026 Revenue Guidance - Has The Bull Case Changed?
Simply Wall St · 03/15 15:13
Assessing Codexis (CDXS) Valuation After Strong Earnings And New ECO Synthesis siRNA Agreement
Simply Wall St · 03/14 13:29
Analysts Are Bullish on These Healthcare Stocks: Korro Bio (KRRO), Health Catalyst (HCAT)
TipRanks · 03/13 08:30
Craig-Hallum Sticks to Its Buy Rating for Codexis (CDXS)
TipRanks · 03/13 08:15
More
About CDXS
Codexis, Inc. is a provider of enzymatic solutions. It is leveraging its CodeEvolver technology platform to discover, develop, enhance, and commercialize novel, high-performance enzymes and other classes of proteins. The Company utilizes its CodeEvolver technology platform to develop optimized enzymes that are used by some pharmaceutical companies to reduce their costs and improve the efficiency and productivity of their manufacturing processes for small molecule therapeutics. It is developing its Enzyme-Catalyzed Oligonucleotide Synthesis (ECO Synthesis) manufacturing platform to enable the scaled manufacture of RNA interference (RNAi) and other RNA-based therapeutics through an enzymatic route. The Company also uses the CodeEvolver platform technology to develop enzymes for the synthesis of RNAi therapeutics through its ECO Synthesis manufacturing platform, where its enzymes are poised to deliver many of the same benefits it offers in pharmaceutical manufacturing.

Webull offers Codexis Inc stock information, including NASDAQ: CDXS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDXS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDXS stock methods without spending real money on the virtual paper trading platform.